and SIPI plan to use this platform initially for the development of recombinant human Factor VIII for the treatment of Haemophilia A.
s ability to leverage the manufacturing process for Ruconest, a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with HAE (Hereditary Angioedema), represents a significant competitive advantage over manufacturers of plasma- (blood) derived products, which are dependent on blood donations.
The US company licensed exclusive rights to commercialise Ruconest in North America for the treatment of acute attacks of HAE as well as other potential future indications from Pharming
A combination of Pharming
with DNage will generate important synergies.
It is intended to stop unauthorised users from altering domain settings, stealing or disabling websites and e-mail systems and domain hijacking to carry out pharming
has acquired 57 issued patents, including 19 in the US as well as several pending patent applications of PPL Therapeutics.
Additional information is available on the Pharming
Sijmen de Vries, Pharming
CEO, commented: We are pleased to have received this US$10 million milestone from our partner Santarus, which significantly strengthens our balance sheet and signals the beginning of a new chapter in the development of the Company.
completed its human lactoferrin filing for a GRAS notification with the FDA and notified the FDA that its hLF is generally recognized as safe for use as an ingredient in functional foods.
It is also testament to the substantial expertise that Pharming
brings to our collaboration to develop a therapy for Pompe's disease.
Record numbers of banks are joining the growing ranks of businesses displaying the Catbird[TM] Pharming
Shield[TM] seal on websites to reassure customers that the site is safe and open for business.
Mr Jaap Blaak, Pharming
's Chairman of the Board of Supervisory Directors, commented: "We are very pleased that Robin can join Pharming
at this exciting time as we complete our transformation from an R&D oriented biotech company to a self-sustainable specialty pharmaceutical company.